![]() |
市場調查報告書
商品編碼
1498658
全球非鴉片類止痛貼市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測Global Non-Opioid Pain Patches Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球非鴉片類止痛貼市場需求預計將從 2023 年的 5.0824 億美元達到近 7.4688 億美元的市場規模,2024-2032 年研究期間複合年成長率為 4.37%。
非鴉片類止痛貼片是一種經皮治療系統,旨在在不使用鴉片類藥物的情況下緩解疼痛。這些貼片通常含有緩解局部疼痛的活性成分,如利多卡因、辣椒素或 NSAID(非類固醇抗發炎藥)。它們用於治療各種類型的疼痛,包括慢性疼痛、神經性疼痛和手術後疼痛。將貼片直接貼在疼痛部位的皮膚上,使藥物隨著時間的推移而穩定地吸收。它提供了鴉片類藥物的更安全替代品,降低了與鴉片類藥物使用相關的成癮風險和副作用。
人們對鴉片類止痛藥的副作用和成癮潛力的認知不斷提高,刺激了對非鴉片類藥物替代品的需求,導致止痛貼的使用量激增。這些貼片透過經皮給藥系統提供局部疼痛緩解,最大限度地減少與口服藥物相關的全身性副作用,同時有針對性地緩解特定區域的不適。貼片配方和遞送機制的技術進步提高了非鴉片類止痛貼片的功效和便利性,使其越來越受到醫療保健專業人員和患者的青睞。緩釋製劑、新型藥物組合和改進的黏合性能等創新有助於更好的疼痛管理結果和患者依從性。此外,人口老化的不斷擴大,加上關節炎、神經病變和肌肉骨骼疾病等慢性疼痛疾病的發病率不斷上升,刺激了市場對非鴉片類止痛貼片的需求,將其作為長期疼痛管理的安全有效的替代品。
此外,旨在遏制鴉片類藥物濫用和推廣非藥物疼痛管理策略的監管舉措鼓勵醫療保健提供者開出止痛貼等非鴉片類藥物替代品,進一步促進市場成長。此外,疼痛貼片的便利性和謹慎性使患者能夠靈活地進行疼痛緩解治療,而無需頻繁給藥或侵入性操作,從而提高他們的生活品質並促進疼痛症狀的自我管理。然而,高昂的成本和有限的保險覆蓋範圍可能會挑戰未來幾年的市場成長。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具還對全球非鴉片類止痛貼片市場的每個細分市場進行了包容性評估。非鴉片類止痛貼產業的成長和趨勢為本研究提供了整體方法。
非鴉片類止痛貼市場報告的這一部分提供了國家和地區層面細分市場的詳細資料,從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲非鴉片類止痛貼片市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。非鴉片類止痛貼片市場的主要參與者包括輝瑞公司、Mylan NV、葛蘭素史克公司、艾爾建、久光製藥有限公司、德成製藥有限公司、Acorda Therapeutics Ltd.、Teikoku Seiyaku Co. Ltd. 。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Non-Opioid Pain Patches Market is presumed to reach the market size of nearly USD 746.88 Million by 2032 from USD 508.24 Million in 2023 with a CAGR of 4.37% under the study period 2024-2032.
Non-opioid pain patches are transdermal therapeutic systems designed to deliver pain relief without the use of opioids. These patches generally comprise active ingredients such as lidocaine, capsaicin, or NSAIDs (nonsteroidal anti-inflammatory drugs) that relieve localized pain. They are used to treat various types of pain, including chronic pain, neuropathic pain, and post-surgical pain. The patch is directly applied to the skin over the painful area, allowing the medication to be absorbed steadily over time. It offers a safer alternative to opioid medications, lowering the risk of addiction & side effects associated with opioid use.
Rising awareness about the adverse effects and addictive potential of opioid-based pain medications has spurred the demand for non-opioid alternatives, leading to a surge in the adoption of pain patches. These patches offer localized pain relief through transdermal drug delivery systems, minimizing systemic side effects associated with oral medications while providing targeted relief to specific areas of discomfort. Technological advancements in patch formulations and delivery mechanisms have enhanced the efficacy and convenience of non-opioid pain patches, making them increasingly preferred among healthcare professionals and patients. Innovations such as extended-release formulations, novel drug combinations, and improved adhesive properties contribute to better pain management outcomes and patient compliance. Moreover, the expanding aging population, together with the spurring incidence of chronic pain conditions such as arthritis, neuropathy, and musculoskeletal disorders, fuels market demand for non-opioid pain patches as a safe and effective alternative for long-term pain management.
Additionally, regulatory initiatives aimed at curbing opioid misuse and promoting non-pharmacological pain management strategies further bolster market growth by encouraging healthcare providers to prescribe non-opioid alternatives like pain patches. Furthermore, the convenience and discreet nature of pain patches offer patients the flexibility to administer pain relief therapy without frequent dosing or invasive procedures, enhancing their quality of life and promoting self-management of pain symptoms. However, high costs and limited insurance coverage may challenge the market growth in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Non-Opioid Pain Patches. The growth and trends of Non-Opioid Pain Patches industry provide a holistic approach to this study.
This section of the Non-Opioid Pain Patches market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Non-Opioid Pain Patches market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Non-Opioid Pain Patches market include Pfizer Inc., Mylan N.V., GlaxoSmithKline Plc, Allergan, Hisamitsu Pharmaceutical Co. Inc., Teh Seng Pharmaceutical Mfg. Co., Acorda Therapeutics Ltd., Teikoku Seiyaku Co. Ltd., IBSA Institut Biochimque SA Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.